# Bristol-Myers Squibb Company (BMY) — Q4-2012 Earnings Results

**Report date:** 2013-01-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Bristol-Myers Squibb Beats on EPS, Stock Up 2.61%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | +10.07% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Bristol-Myers Squibb reported a better-than-expected EPS for the fourth quarter of 2012, which led to a positive stock reaction, with shares rising by 2.61%. The company did not provide any revenue figures or guidance, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of underlying strength, but the lack of additional details could lead to cautious sentiment moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2012_